Abvc biopharma announces fiscal year 2022 financial and operational results

Fremont, ca, march 31, 2023 (globe newswire) -- via newmediawire -- abvc biopharma, inc. (nasdaq: abvc), a biotechnology company specializing in botanically based solutions that seeks to deliver high efficacy and low toxicity to improve health outcomes, today announced its financial and operating results for the fiscal year ended december 31, 2022.
ABVC Ratings Summary
ABVC Quant Ranking